Joshua Keller

Dr. Joshua Keller

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Journal of Applied Physiology
Verified
Journal Article
Closed access
Joshua KellerJoshua Keller
Joshua Keller
MTMiranda K. Traylor
Miranda K. Traylor
SGSylvie M. Gray
Sylvie M. Gray
EHEthan Hill
Ethan Hill
JWJoseph P. Weir
Joseph P. Weir
Men exhibit greater values of reactive hyperemia than women even when controlling for the magnitude of desaturation during transient ischemia. Factors other than the ischemic vasodilatory stimulus, such as skeletal muscle mass and quality, likely provoke the commonly reported sex differences in reactive hyperemia measured by near-infrared spectroscopy.

13 September 2021 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
Joshua KellerJoshua Keller
Joshua Keller
KKKatie G. Kennedy
Katie G. Kennedy

18 July 2019 in Sports
Verified
Journal Article
Open access
PDF file
JAJohn Paul Anders
John Paul Anders
CSCory M. Smith
Cory M. Smith
Joshua KellerJoshua Keller
Joshua Keller
EHEthan Hill
Ethan Hill
THTerry Housh
Terry Housh
GJGlen O. Johnson
Glen O. Johnson
The purpose of this study was to compare the composite, inter-individual, and intra-individual differences in the patterns of responses for electromyographic (EMG) and mechanomyographic (MMG) amplitude (AMP) and mean power frequency (MPF) during fatiguing, maximal, bilateral, and isokinetic leg extension muscle actions. Thirteen recreationally active men (age = 21.7 ± 2.6 years; body mass = 79.8 ± 11.5 kg; height = 174.2 ± 12.7 cm) performed maximal, bilateral leg extensions at 180°·s−1 until the torque values dropped to 50% of peak torque for two consecutive repetitions. The EMG and MMG signals from the vastus lateralis (VL) muscles of both limbs were recorded. Four 2(Leg) × 19(time) repeated measures ANOVAs were conducted to examine mean differences for EMG AMP, EMG MPF, MMG AMP, and MMG MPF between limbs, and polynomial regression analyses were performed to identify the patterns of neuromuscular responses. The results indicated no significant differences between limbs for EMG AMP (p = 0.44), EMG MPF (p = 0.33), MMG AMP (p = 0.89), or MMG MPF (p = 0.52). Polynomial regression analyses demonstrated substantial inter-individual variability. Inferences made regarding the patterns of neuromuscular responses to fatiguing and bilateral muscle actions should be considered on a subject-by-subject basis.

Joshua KellerJoshua Keller
Joshua Keller
THTerry Housh
Terry Housh
EHEthan Hill
Ethan Hill
CSCory M Smith
Cory M Smith
RSRichard J. Schmidt
Richard J. Schmidt
GJGlen O. Johnson
Glen O. Johnson
Shilajit is a safe, fluvic mineral complex exudate that is common to Ayurvedic medicine and is composed of fulvic acids, dibenzo-α-pyrones, proteins, and minerals. The purpose of this study was to examine the effects of 8 weeks of Shilajit supplementation at 250 mg·d− 1 (low dose) and 500 mg·d− 1 (high dose) versus placebo on maximal voluntary isometric contraction (MVIC) strength, concentric peak torque, fatigue-induced percent decline in strength, and serum hydroxyproline (HYP). Sixty-three recreationally-active men ( $$ \overline{X} $$ ± SD: 21.2 ± 2.4 yr.; 179.8 ± 6.3 cm; 83.1 ± 12.7 kg) volunteered to participate in this study. The subjects were randomly assigned to the high dose, low dose, or placebo group (each group: n = 21). During pre-supplementation testing, the subjects performed 2 pretest MVICs, 2 sets of 50 maximal, bilateral, concentric isokinetic leg extensions at 180°·s− 1 separated by 2-min of rest, and 2 posttest MVICs. Following 8 weeks of supplementation, the subjects repeated the pre-supplementation testing procedures. In addition, the groups were dichotomized at the 50th percentile based on pre-supplementation MVIC and baseline HYP. Mixed model ANOVAs and ANCOVAs were used to statistically analyze the dependent variables for the total groups (n = 21 per group) as well as dichotomized groups. For the upper 50th percentile group, the post-supplementation adjusted mean percent decline in MVIC was significantly less for the high dose group (8.9 ± 2.3%) than the low dose (17.0 ± 2.4%; p = 0.022) and placebo (16.0 ± 2.4%; p = 0.044) groups. There was no significant (p = 0.774) difference, however, between the low dose and placebo groups. In addition, for the upper 50th percentile group, the adjusted mean post-supplementation baseline HYP for the high dose group (1.5 ± 0.3 μg·mL− 1) was significantly less than both the low dose (2.4 ± 0.3 μg·mL− 1; p = 0.034) and placebo (2.4 ± 0.3 μg·mL− 1, p = 0.024) groups. The results of the present study demonstrated that 8 weeks of PrimaVie® Shilajit supplementation at 500 mg·d− 1 promoted the retention of maximal muscular strength following the fatiguing protocol and decreased baseline HYP. Thus, PrimaVie® Shilajit supplementation at 500 mg·d− 1 elicited favorable muscle and connective tissue adaptations.

1 November 2021 in Physiological Measurement
Verified
Journal Article
Closed access
Joshua KellerJoshua Keller
Joshua Keller
JAJohn Paul V Anders
John Paul V Anders
TNTyler J Neltner
Tyler J Neltner
THTerry J Housh
Terry J Housh
RSRichard J Schmidt
Richard J Schmidt
GJGlen O Johnson
Glen O Johnson
It remains to be fully elucidated if there are sex-specific physiological adjustments within the human neuromuscular and vascular systems that contribute to symptoms of fatigue during a sustained bilateral task. This, in part, is likely due to various limitations in experimental design such as an inability to independently record force fluctuations from each limb. Objective . Therefore, the purpose of the current study was to examine the fatigue-induced changes in muscle excitation, force fluctuations, skeletal muscle tissue saturation (StO 2 ), and muscle blood flow resulting from a sustained, bilateral task. Approach . Thirty healthy, college-aged adults (15 males, 15 females) performed a bilateral leg task at 25% of maximum voluntary isometric (MVIC). Before and after the task, MVICs were completed. Resting and post-task femoral artery blood flow (FABF) were determined. Muscle excitation was quantified as electromyographic amplitude (EMG AMP) from the right and left vastus lateralis. During the task, force fluctuations were determined independently from each leg. The StO 2 signal was collected with a near-infrared spectroscopy device attached to the right vastus lateralis. The rate of change in these variables was calculated via simple linear regression. The exercise-induced magnitude of change in MVIC (i.e. performance fatigability) and FABF (i.e. active hyperemia) was determined. Main Results . There was no sex difference in the percent decline in MVIC (20.5 ± 20.1% versus 16.4 ± 3.5%; p > 0.05). There were no inter-leg differences in EMG AMP or force fluctuations. The males exhibited a faster rate of increase in EMG AMP ( b = 0.13 versus b = 0.08; p < 0.001), whereas the females exhibited a slower rate of decline in StO 2 ( b = −0.049 versus b = −0.080). There was no sex difference in force fluctuations or change in FABF. Significance . Males and females likely have different neuromuscular strategies and muscle characteristics, but these did not elicit a sex difference in performance fatigability.

15 June 2022 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
EHEthan Hill
Ethan Hill
PRPaola M. Rivera
Paola M. Rivera
CPChris E. Proppe
Chris E. Proppe
DRDavid H. Gonzalez Rojas
David H. Gonzalez Rojas
AWAaron M. Wizenberg
Aaron M. Wizenberg
Joshua KellerJoshua Keller
Joshua Keller
The application of blood flow restriction induces greater acute neuromuscular fatigue relative to nonrestricted conditions. Resistance exercise with blood flow restriction elicited a greater reduction in twitch responses. These neuromuscular differences might explain the more favorable adaptations achieved with blood flow restriction that are likely a function of metabolic stress and subsequent changes in efferent neural drive.